Table 2.
Exposure Status |
Date | All participants | Group 2 participants | ||
---|---|---|---|---|---|
N | mean percent (%) predicted +/− Standard Deviation* |
N | mean percent (%) predicted +/− Standard Deviation* |
||
FEV1 | |||||
Unexposed | Jan 2003 | 68 | 86.5+/−16.8 | 30 | 80.3+/−15.6 |
May 2004 | 66 | 88.6+/−12.4 | 31 | 82.4+/−17.4 | |
Oct 20O4 | 71 | 85.5+/−17.2 | 31 | 82.2+/−17.6 | |
Jun 2006 | 62 | 86.2+/−17.0 | 32 | 84.3+/−16.7 | |
Sept 2007 | 62 | 83.2+/−20.6 | 27 | 83.9+/−15.7 | |
May 2008 | 73 | 79.8+/−20.2 | 30 | 79.7+/−16.3 | |
Exposed | March 2003 | 58 | 84.9+/−17.0 | 26 | 79.5+/−16.5 |
Feb 2003 | 79 | 84.5+/−18.2 | 33 | 84.8+/−16.3 | |
March 2003 | 79 | 84.3+/−19.2 | 35 | 84.7+/−16.7 | |
Sept 2006 | 47 | 80.9+/−18.7 | 34 | 82.6+/−16.3 | |
December 2009 | 55 | 84.3+/−18.5 | 23 | 82.5+/−16.9 | |
PEF | |||||
Unexposed | Jan 2003 | 68 | 99.0+/−17.9 | 30 | 92.4+/−17.6 |
May 2004 | 66 | 102.4+/−21.6 | 31 | 92.5+/−22.6 | |
Oct 20O4 | 71 | 97.1+/−21.1 | 31 | 94.3+/−20.2 | |
Jun 2006 | 62 | 97.2+/−19.6 | 32 | 91.5+/−17.8 | |
Sept 2007 | 62 | 94.9+/−23.7 | 27 | 94.8+/−17.3 | |
May 2008 | 73 | 91.5+/−23.2 | 30 | 89.9+/−19.4 | |
Exposed | March 2003 | 58 | 97.4+/−20.1 | 26 | 91.4+/−19.3 |
Feb 2003 | 79 | 98.1+/−22.3 | 33 | 97.3+/−18.4 | |
March 2003 | 79 | 98.1+/−22.9 | 35 | 96.8+/−19.1 | |
Sept 2006 | 47 | 92.9+/−19.9 | 34 | 94.7+/−17.1 | |
December 2009 | 55 | 96.6+/−22.2 | 23 | 94.3+/−21.5 |
Percent predicted FEV1 standardized by age, gender, race, height, and weight (Hankinson et al. 1999); Group 2= participants in ≥4 exposure studies